Compare ENLV & FIRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENLV | FIRY |
|---|---|---|
| Founded | 2005 | N/A |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.0M | 148.6M |
| IPO Year | 2014 | 2020 |
| Metric | ENLV | FIRY |
|---|---|---|
| Price | $0.53 | $9.74 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | ★ 343.3K | 122.3K |
| Earning Date | 05-29-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.52 | $9.39 |
| 52 Week High | $2.10 | $10.74 |
| Indicator | ENLV | FIRY |
|---|---|---|
| Relative Strength Index (RSI) | 26.36 | N/A |
| Support Level | N/A | N/A |
| Resistance Level | $1.25 | N/A |
| Average True Range (ATR) | 0.05 | 0.00 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 3.53 | 0.00 |
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.